123 related articles for article (PubMed ID: 29933495)
1. [Baseline Incidence of HPV-Associated Invasive and in Situ Cancers in Germany Prior to Potential Vaccination Effects].
Sophia Rudolph CE; Katalinic A
Gesundheitswesen; 2019 Dec; 81(12):993-1000. PubMed ID: 29933495
[TBL] [Abstract][Full Text] [Related]
2. Cancer incidence in Germany attributable to human papillomavirus in 2013.
Buttmann-Schweiger N; Deleré Y; Klug SJ; Kraywinkel K
BMC Cancer; 2017 Oct; 17(1):682. PubMed ID: 29037233
[TBL] [Abstract][Full Text] [Related]
3. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
[TBL] [Abstract][Full Text] [Related]
4. Risk of human papillomavirus-associated cancers among persons with AIDS.
Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
[TBL] [Abstract][Full Text] [Related]
5. Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected Hispanics living in the United States.
Ortiz AP; Engels EA; Nogueras-González GM; Colón-López V; Soto-Salgado M; Vargas A; Machin M; Shiels MS
Cancer; 2018 Dec; 124(23):4520-4528. PubMed ID: 30345506
[TBL] [Abstract][Full Text] [Related]
6. Burden of human papillomavirus infection and related diseases in Israel.
Shavit O; Roura E; Barchana M; Diaz M; Bornstein J
Vaccine; 2013 Nov; 31 Suppl 8():I32-41. PubMed ID: 24229717
[TBL] [Abstract][Full Text] [Related]
7. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
8. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus-Attributable Cancers - United States, 2012-2016.
Senkomago V; Henley SJ; Thomas CC; Mix JM; Markowitz LE; Saraiya M
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):724-728. PubMed ID: 31437140
[TBL] [Abstract][Full Text] [Related]
10. HPV-related cancers after solid organ transplantation in the United States.
Madeleine MM; Finch JL; Lynch CF; Goodman MT; Engels EA
Am J Transplant; 2013 Dec; 13(12):3202-9. PubMed ID: 24119294
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.
Smith JS; Backes DM; Hoots BE; Kurman RJ; Pimenta JM
Obstet Gynecol; 2009 Apr; 113(4):917-924. PubMed ID: 19305339
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
Gilbert DC; Wakeham K; Langley RE; Vale CL
Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
[TBL] [Abstract][Full Text] [Related]
14. [Analysis on cancer incidence and mortality attributed to human papillomavirus infection in China, 2016].
Yuan MW; Wang HH; Duan RF; Xu KP; Hu SY; Qiao YL; Zhang Y; Zhao F
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 May; 43(5):702-708. PubMed ID: 35589576
[No Abstract] [Full Text] [Related]
15. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.
Gillison ML; Chaturvedi AK; Lowy DR
Cancer; 2008 Nov; 113(10 Suppl):3036-46. PubMed ID: 18980286
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological dynamic modeling of human papillomavirus-related diseases to assess vaccination strategies in Argentina.
Borracci RA; Segal SV; Méndez JH
Medicina (B Aires); 2018; 78(5):315-328. PubMed ID: 30285924
[TBL] [Abstract][Full Text] [Related]
17. Update of HPV-associated female genital cancers in the United States, 1999-2004.
Watson M; Saraiya M; Wu X
J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
[TBL] [Abstract][Full Text] [Related]
19. Worldwide burden of cancer attributable to HPV by site, country and HPV type.
de Martel C; Plummer M; Vignat J; Franceschi S
Int J Cancer; 2017 Aug; 141(4):664-670. PubMed ID: 28369882
[TBL] [Abstract][Full Text] [Related]
20. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
